Related Experiment Video
Updated: Aug 14, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
The Role of Wearable Devices in the Management of Congenital Heart Disease
Inés Martínez-Saludes1, Cristina Ruiz-Herguido2, Joan Sanchez de Toledo2,3,4
1Cardiology Department, Hospital Clínic de Barcelona, 08036 Barcelona, Spain.
Insights
Wearable devices offer continuous remote monitoring for congenital heart disease (CHD) patients, improving care beyond standard follow-ups. Research also highlights their role in tracking physical activity for better health outcomes in CHD.
Area of Science:
- Cardiology
- Biomedical Engineering
- Digital Health
Background:
- Congenital heart disease (CHD) presents complex lifelong healthcare challenges, increasing morbidity and mortality.
- Patients with CHD experience risks from hemodynamic shifts, arrhythmias, and heart failure decompensation.
- Standard outpatient monitoring is insufficient for the continuous needs of CHD patients and their families.
Purpose of the Study:
- To review the emerging role of wearable devices for continuous and remote monitoring in congenital heart disease.
- To explore the application of wearable technology in assessing physical activity for CHD patients.
- To identify current limitations hindering the clinical integration of wearable devices for CHD management.
Main Methods:
- Selective literature review of wearable technology applications in pediatric and adult congenital heart disease.
- Analysis of studies focusing on clinical tracking and physical activity assessment using wearable devices.
- Examination of research on the integration challenges of wearable technology in routine clinical practice.
Main Results:
- Wearable devices provide a key solution for continuous and remote patient monitoring.
- Increasing research focuses on wearable technology for assessing physical activity, a critical health determinant in CHD.
- Existing literature covers both pediatric and adult CHD populations.
Conclusions:
- Wearable technology shows significant promise for enhancing the management of congenital heart disease through continuous monitoring.
- Assessing physical activity via wearables is a growing area of research crucial for CHD patient outcomes.
- Overcoming current limitations is essential for the widespread clinical adoption of wearable devices in CHD care.
Abstract:
Patients with congenital heart disease (CHD) represent a special healthcare challenge due to their high complexity, which accompanies them throughout all life stages. Consequently, this population faces increased morbidity and mortality rates, often linked to hemodynamic shifts in pulmonary flow or cardiac output. These risks are further compounded by potential arrhythmias and heart failure decompensation, which may lead to the progressive progression toward advanced stages of the disease. Unfortunately, standard outpatient follow-up is often not capable of responding to the continuous monitoring needs presented by these patients and their families. This selective review frames information on the wearable devices that have emerged as a key solution for continuous and remote monitoring. Beyond clinical tracking, research is increasingly focusing on their role in assessing physical activity-a critical determinant of health outcomes in the CHD population. This review examines the existing literature on wearable technology in both pediatric and adult patients while also addressing the current limitations that hinder their integration into routine clinical practice.
Related Concept Videos
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Holter Monitor: 24-Hour Monitoring
Cardiomyopathy II: Dilated Cardiomyopathy
Rheumatic Heart Disease III: Medical Management

